InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Karkus Ted William, Chief Executive Officer. Insider active across 1 companies, notably ProPhase Labs, Inc.. Cumulatively, 5 reports have been logged. Total volume traded: €283k. The latest transaction was disclosed on 23 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€842,535450,000 shares@ €1.872374.8% of flow
Common Stock, par value $0.005
SEC:0001493152-22-015068:0·
€141,69733,943 shares@ €4.1746100.0% of flow
Common Stock, par value $0.005
SEC:0001493152-21-014015·
Ideal exit: 28 Feb 2022 (T+270)
€141,69733,943 shares@ €4.174627.22% mcap12.6% of flow
Common Stock, par value $0.005
SEC:0001493152-21-014015:0·
Ideal exit: 28 Feb 2022 (T+270)
0120,000 shares0
Common Stock, par value $0.005
SEC:0001493152-21-010909·
0120,000 shares0
Common Stock, par value $0.005
SEC:0001493152-21-010909:0·
5 of 5 declarations
About Karkus Ted William
Ted William Karkus is the Chief Executive Officer and Chairman of ProPhase Labs, Inc. In this role, he oversees the company's operations and strategy. With extensive experience in the health and wellness products sector, he plays a key role in developing new products and expanding markets. His leadership and commitment to innovation are major assets.
